Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
about
TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKLRecruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signalingTTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activationCIKS, a connection to Ikappa B kinase and stress-activated protein kinaseA diverse family of proteins containing tumor necrosis factor receptor-associated factor domainsA novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2.The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complexVaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growthA20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activityHuman glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signalsBS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathwayStress-induced decrease in TRAF2 stability is mediated by Siah2Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesisTransactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNFMKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokinesThe atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathwayPKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitinationRequirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transductionActivation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane proteinThe role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.The Drosophila sterile-20 kinase slik controls cell proliferation and apoptosis during imaginal disc developmentProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsEffect of TACI signaling on humoral immunity and autoimmune diseasesInterleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase PathwayA RING to rule them all? Insights into the Map3k1 PHD motif provide a new mechanistic understanding into the diverse roles of Map3k1TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosisNF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylationIKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2Tumor necrosis factor receptor-associated factors (TRAFs)Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signalingRas participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathwaysHsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitinationThe zinc finger protein A20 targets TRAF2 to the lysosomes for degradationThe LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development
P2860
Q21092160-FAD88D87-4F13-4B2B-B8B6-31DCB2E1F76DQ22253441-AFE598B5-A49A-4F12-996E-B5757BB82B2DQ22253885-BF4E9AFC-343D-4F01-B831-7D244A958C54Q24290148-1BA45853-9D48-4C1A-9042-01295D03F4FEQ24291050-68100EAA-EE9F-465A-BFD5-86C6C02FACB2Q24292059-7F6B85CC-37C3-4CF4-95FF-5B423E176249Q24292137-5618C525-426D-49A0-B9CA-A2B24BD169A3Q24301337-D14BAD90-67AD-40B8-8013-218A17660C17Q24306761-51A44FB2-39C2-4A41-A8C6-990E8524FD0CQ24308802-CEB3A721-C523-4C0D-A46C-7D3FEB7745B1Q24316467-6CC6FEE4-390C-4289-873E-BADA94BB6F27Q24320308-15C460B2-A969-48B4-AF7A-9A4A011BBE9BQ24537608-B920EF53-AFB7-4D28-BFA2-CC519B42C46CQ24539054-87E8D98D-AC8D-4F8F-8CD3-779BFF2806ADQ24540207-ED7A2A68-5AFA-49F3-9FB1-D3020D0D370DQ24550930-90092330-684B-4DC0-B42B-80FB4B9B0857Q24550953-3711D929-2E4A-496C-A806-6D5BCCD92034Q24601753-8015CBD5-00FF-4E6B-8718-60261D501DA5Q24630760-DAB3E571-C229-4CAB-ADD7-4E540DB824C6Q24652618-9F45DED4-EC6E-4659-AE04-2A5704D4FE7EQ24676400-53F63EB8-805B-4693-A27A-06D14239C53BQ24683297-6A900B25-17F5-4E20-8205-DA7373C5D55AQ24805207-0A40ACF8-ACD2-4EC7-8492-FB28CA126B41Q24806702-BC5B1AC2-BF6C-4CB2-9D28-654B8D6F5891Q26773613-C7E7C1A0-1293-497F-9F95-554CDCA4EDE3Q26995571-0C08C5BE-7456-49C0-AF0E-26A09A526921Q27473476-F2C508D1-218C-46B4-BCB3-EE702030B8D5Q28083145-1C1E5CF5-46CC-4DC4-9C0A-372D2FCE8060Q28138885-AEDA2311-6DF0-45B2-9D21-D47C7BF9CEE3Q28141521-56CDC1FB-56D9-47AF-8BC6-6A8120C880C0Q28198356-0B27BED7-0D38-4D52-85CA-24897C1E88BCQ28199382-E126E07A-48E8-4E06-BB16-77F0EB0B4BECQ28207396-8FF32AC6-9ABF-4735-A647-0B5919F0F3DCQ28211306-8A203F0A-357A-4E85-A0C9-693D84CA4849Q28361340-3085B962-01DF-46F7-BE6F-5D779581FE96Q28361904-3166482C-F1BE-4FF1-8A86-AAE54AEC1FF1Q28384960-76F4F0FA-B5E3-4B9F-8AA7-03ED86198E49Q28505337-A142DA19-4FE5-4AAE-AB86-20969A55D8D5Q28509686-B0C1B25B-8608-40AB-89F2-34407F78B369Q28512132-AC11F6A4-CC26-40C0-8A66-731BEFC741F7
P2860
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Signaling by proinflammatory c ...... amino-terminal effector domain
@ast
Signaling by proinflammatory c ...... amino-terminal effector domain
@en
Signaling by proinflammatory c ...... amino-terminal effector domain
@nl
type
label
Signaling by proinflammatory c ...... amino-terminal effector domain
@ast
Signaling by proinflammatory c ...... amino-terminal effector domain
@en
Signaling by proinflammatory c ...... amino-terminal effector domain
@nl
prefLabel
Signaling by proinflammatory c ...... amino-terminal effector domain
@ast
Signaling by proinflammatory c ...... amino-terminal effector domain
@en
Signaling by proinflammatory c ...... amino-terminal effector domain
@nl
P2093
P2860
P356
P1433
P1476
Signaling by proinflammatory c ...... amino-terminal effector domain
@en
P2093
P2860
P304
P356
10.1101/GAD.13.10.1297
P407
P577
1999-05-15T00:00:00Z